CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

Greening Up Our Act to Secure Supply: The Push for Pharma to Move Towards More Environmentally-friendly Propellants

Global warming accelerated by increased consumption of potent greenhouse gases has become a serious public concern and has triggered initiatives to further reduce the carbon footprint of all industries. Over recent decades, there has been a transition to more environmentally responsible industry practices. Lei Mao, Mark Knowles and Ron Roscher at Recipharm also stipulate that these gases have been shown to have an impact on global warming due to their high global warming potential (GWP) and long atmospheric life (AL).

 

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026